Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer release label changed from v3.7.2 to v3.8.0, with no change to the clinical trial record content.SummaryDifference0.0%

- Check22 days agoChange DetectedA sitewide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence,” with both terms appearing during the transition.SummaryDifference0.2%

- Check29 days agoChange DetectedThe website’s footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check36 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check57 days agoChange DetectedThe revision history now shows a new revision entry for v3.7.0 and removes the previous v3.6.6, reflecting an update to the page's revision history.SummaryDifference0.0%

- Check78 days agoChange DetectedHistory now shows a new entry Revision: v3.6.6. The previous entry Revision: v3.6.5 has been removed.SummaryDifference0.0%

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.